The higher expression of Plk5 in primary tumor could be a response to the DNA damages, but Plk5 silencing by promoter hypermethylation [10–12] or mutation in the PBD domain to disrupt the expression (as we reported here) allows tumor cells to entering S phase for proliferation disregard their DNA damages. The gene discussed is PLK5; the disease is neoplasm.